A community-based @entity311 control programme in Saradidi, Kenya provided @entity503 treatment for @entity311 in each village beginning in May 1982. @entity311 was holoendemic in Saradidi. Treatment was provided by volunteer community health workers chosen and supported by the village. Consumption of the drug and characteristics of @entity1 treated were recorded. Between 1 September 1982 to 31 August 1983, 40,649 treatments with @entity503 were given to village residents. The treatment rate per @entity1 in the mid-year population was 1.24. However, at least 41.8% of the mid-year population of 32,650 did not receive a single treatment. Multiple treatments were given to 50.5% of @entity1 treated at least once and 13.4% of 13,879 @entity1 treated at least once received five or more treatments during the year. Consumption patterns were not random: they were higher in females, in @entity1 above 30 years of age and in the area with greater community organization and community participation. There is need to ascertain the reasons why so large a proportion of the population never received a single treatment in this highly malarious area and why adults who should not have had a high frequency of clinical @entity311 were treated so often. Nonetheless, the results demonstrate that volunteer community health workers can effectively provide treatment for @entity311 .

Consumption of chloroquine phosphate provided for treatment of XXXX by volunteer village health workers in Saradidi, Kenya.

@entity1 :: ('9606', 'Species') :: ['person', 'persons'] @entity311 :: ('MESH:D008288', 'Disease') :: ['Malaria', 'malaria'] @entity503 :: ('MESH:D002738', 'Chemical') :: ['chloroquine']
@entity311 :: (MESH:D008288,Disease) :: ['malaria']
